ABC Arthritis



Search:

Rheumetoid Arthritis

Arthritis Resources & Information
Would you like to
contribute to this site?

Arthritis Menu

Submit an Article
Submit a Tip
Place your Ad
Add URL
Arthritis Questions?
Contact Us


Related Topics:

Rheumatoid Arthritis
Rheumatoid Arthritis Diagnosis
Rheumatoid Arthritis Knee
Rheumatoid Arthritis Test
Rheumatoid Arthritis Info
Cure For Rheumatoid Arthritis
Rheumetoid Arthritis



Other Channels:

 Rheumatoid Diseases 
 Arthritis Symptoms 
 Arthritis Causes 
 Arthritis Pain 
 Joint Pain Information 
 Joint Pain Locations 
 Arthritis Pain Relief 
 Arthritis Body Spots 
 Hip Arthritis 
 Knee Arthritis 
 Finger Arthritis 
 Hand Arthritis 
 Types Of Arthritis 
 Rheumatoid Arthritis 
 Psoriatic Arthritis 
 Osteoarthritis 
 Juvenile Arthritis 
 Lupus Arthritis 
 Ankylosing Spondylitis 
 Rheumatism 
 Arthritis Treatments 
 Arthritis Exercises 
 Arthritis Medication 
 Glucosamine Chondroitin 
 Natural Arthritis Treatment 
 Diet To Help Arthritis 
 Alternative Arthritis Treatment 
 Arthritis Remedies 
 Arthritis Home Remedies 
 Types Of Arthritis Treatment 
 Arthritis In Animals 
 Arthritis Resources 
 Support For Arthritis 
 Arthritis Pictures 
 Arthritis Information 
Category Leaders: Rheumetoid Arthritis
Recent Questions and Answers
Question: What is rheumatoid arthritis?
Answer: [read entire answer]
 
Recent Rheumetoid Arthritis News:  
Rheumatoid Arthritis - Bing News

Norville Raises Rheumatoid Arthritis Awareness - CBS 2 KCAL 9
"In my mom's case, her level of health went down pretty quickly and we used to say at Christmas, 'mom, what do you want for Christmas or your birthday' and she would say, 'all I want is a new pair of arms and legs,'" Emmy-award winning journalist and ...

Vertex plans midstage trial of arthritis drug - MSN Money
CAMBRIDGE, Mass. (AP) - Vertex Pharmaceuticals Inc. said Wednesday it plans to start a midstage study of its drug candidate VX-509 as a treatment for rheumatoid arthritis. The company said the 12-week trial will enroll about 200 patients and start in ...

Back pain and rheumatoid arthritis cost €750m in sick days - Irish Examiner
BACK PAIN, rheumatoid arthritis and similar conditions are costing the economy €750 million a year, as they account for half of all the sick days taken by workers. The report on musculoskeletal disorders (MSDs) released in Brussels showed early ...

Vertex Pharma To Begin Phase 2 Proof-of-concept Clinical Trial For VX ... - RTT News
(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX: News ) said that it plans to initiate a phase 2 proof-of-concept clinical trial for VX-509. The 12-week trial is expected to enroll approximately 200 patients with moderate to severe rheumatoid arthritis ...

UPDATE 1-Roche seeks approval for rheumatoid arthritis drug - Reuters
ZURICH, Sept 30 (Reuters) - Swiss drugmaker Roche Holding AG ( ROG.VX ) said it had filed to extend the use of RoActemra in Europe to inhibit the progression of joint damage and to improve physical function in patients with rheumatoid arthritis (RA ...

Rss Feed Reader
Increased Web Site Traffic
 
Additional Rheumetoid Arthritis Resources:  

1. Rheumatoid Arthritis | Rheumatoid Arthritis
Rheumatoid arthritis is traditionally thought to be a chronic, inflammatory
autoimmune disorder that results in the immune system attacking the joints, ...


2. Rheumatoid Arthritis (RA) Causes, Symptoms, Diagnosis, Treatment ...
Learn more about Remicade, a medication for rheumatoid arthritis. ... The
symptoms of rheumatoid arthritis interfere with work for many people. ...


3. Rheumatoid arthritis symptoms - by S J - Helium
Recognizing the Symptoms of Rheumatoid Arthritis Over 3 million people suffer
from rheumetoid arthritis. It is one of about 8 different arthritic..., SJ.



Want your site featured on this page?
 

Want your site featured on this targeted page?


Get your Arthritis questions answered... Subscribe to our
Arthritis
Newsletter FREE!

Your First Name:

Your Email Address:



Enter above security code





Arthritis Partner Sites
Copyright © ABCArthritis.com, 2009. All rights reserved.
Contact Us | Privacy Policy | Terms of Use